Abstract
Cognitive deficits are present in the majority of psychosis patients. They range across various domains, such as working memory, and executive functioning, and are linked to neurobiological changes, including changes in gray matter volume. In this study, we explored data-driven clustering solutions using behavioural, demographic, psychological and structural brain data, but no clinical data, in a cross-diagnostic sample combining affective (N=51) and non-affective (N=111) psychosis patients as well as healthy controls (N=55). The goal of the study was (1) to test classification sensitivity of diagnostic groups using data without diagnostic information, and (2) to explore identification of potential cognitive phenotypes. We used K-means and spectral clustering, investigating two-, three- and four-cluster solutions, and group-membership matching. We then explored cognitive deficits and symptom expression within the four-cluster solution. Our results revealed best group-cluster matching using PCA-pre-selected only non-brain, mostly cognitive, features. The three groups were clustered with medium sensitivity, correctly identifying between 44% and 78% of individuals per group. More importantly, however, clustering using four clusters allowed the identification of cognitive phenotypes, that significantly varied in clinical and cognitive impairment. We identified one cluster expressing the lowest symptom scores and unimpaired cognition, one other cluster with the highest symptom scores, especially negative symptoms, and global cognitive impairments, across all domains, and two intermediate clusters. In conclusion, these results provide evidence for cognitive phenotypes with specific symptom expressions combining individuals with different overall diagnoses. The clear link between the cognitive deficits and symptoms indicates the need for the development of cognition-based interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
FK received funding from the European Unions Horizon 2020 [Grant number 754462].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at: https://www.humanconnectome.org/study/human-connectome-project-for-early-psychosis
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest: None of the authors declares a conflict of interest.
Funding: FK received funding from the European Union’s Horizon 2020 [Grant number 754462].
Data Availability
All data produced in the present study are available upon reasonable request to the authors
